TD Asset Management
IMNM icon

TD Asset Management’s Immunome IMNM Stock Holding History

TD Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
719,272
+24,338
+4% +$521K 0.01% 565
2026
Q1 		$15.2M Sell
694,934
-64,258
-8% -$1.43M 0.01% 560
2025
Q4 		$16.3M Buy
759,192
+57,912
+8% +$1.02M 0.01% 549
2025
Q3 		$8.21M Buy
701,280
+95,750
+16% +$952K 0.01% 701
2025
Q2 		$5.63M Sell
605,530
-1,232
-0.2% -$10.1K ﹤0.01% 753
2025
Q1 		$4.08M Buy
606,762
+183,460
+43% +$1.76M ﹤0.01% 813
2024
Q4 		$4.5M Buy
423,302
+28,684
+7% +$347K ﹤0.01% 814
2024
Q3 		$5.67M Buy
394,618
+69,412
+21% +$986K 0.01% 770
2024
Q2 		$3.93M Buy
325,206
+39,400
+14% +$616K ﹤0.01% 818
2024
Q1 		$7.05M Buy
285,806
+158,526
+125% +$3.22M 0.01% 691
2023
Q4 		$1.36M Hold
127,280
– – ﹤0.01% 1112
2023
Q3 		$1.06M Buy
+127,280
New +$935K ﹤0.01% 1127

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

TD Asset Management's IMNM Position: Q2 2026 in Review

TD Asset Management increased its Immunome (IMNM) stake by 3.5% in Q2 2026, buying an estimated $521K and bringing the position to 719,272 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #565.

TD Asset Management first reported a position in IMNM in Q3 2023 and has held it in 12 quarters since. The position peaked at $16.3M in Q4 2025. 127 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • TD Asset Management held 719,272 shares of Immunome worth $15.2M as of Q2 2026.
  • TD Asset Management bought 24,338 Immunome shares in Q2 2026, an estimated $521K.
  • Immunome made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #565 holding.
  • TD Asset Management first reported a position in Immunome in Q3 2023 and has held it in 12 quarters since.
  • TD Asset Management's Immunome position peaked at $16.3M in Q4 2025.
  • 127 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.